We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Novel Lewis Acid Catalyzed (E)/(Z)-Arylidene Thiohydantoin Formation
Poster

Novel Lewis Acid Catalyzed (E)/(Z)-Arylidene Thiohydantoin Formation

Novel Lewis Acid Catalyzed (E)/(Z)-Arylidene Thiohydantoin Formation
Poster

Novel Lewis Acid Catalyzed (E)/(Z)-Arylidene Thiohydantoin Formation

Abstract

The novel Lewis acid catalyzed condensation of aldehydes with 3-alkyl-1-methyl-thioxo-imidazolidin-4-ones (thiohydantoins) to generate the corresponding (E)/(Z) 5-arylidene-3-alkyl-1-methyl-2-thioxo-imidazolidin-4-ones (arylidene thiohydantoins) is presented. A survey of various catalysts was conducted (either indium(III) triflate, aluminum trichloride, or boron trifluoride diethyl etherate) and compared with the uncatalyzed reactions.

In most examples, the Lewis acid promoted catalysis yielded reactions exhibiting increased reactivity, conversion and purity profiles as compared to the uncatalyzed reactions. Since arylidene thiohydantoins are reported in the literature as being biologically relevant moieties for antimicrobial, antiviral, immunosuppressive and potentially anticonvulsant indications, this validated protocol was then used as part of our parallel synthesis efforts to generate a library of approximately 400 target compounds.

Advertisement